Integrated Biopharma Inc (INBP) — 10-Q Filings

10-Q Filings (6)

• INBP Net Income Halves Amidst Sales and Profitability Decline — Nov 10, 2025 Risk: high
  INTEGRATED BIOPHARMA INC (INBP) reported a significant decline in net income for the three months ended September 30, 2025, falling to $123,000 from $259,000 in
• Integrated Biopharma Files Q3 2025 10-Q — May 14, 2025 Risk: medium
  Integrated Biopharma Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $30,335,620 and total liabilities of $30,300
• Integrated Biopharma Reports Q2 2025 Results — Feb 13, 2025 Risk: medium
  Integrated Biopharma Inc. filed its 10-Q for the period ending December 31, 2024. The company reported total assets of $30.34 million and total liabilities of $
• Integrated Biopharma Q1 Earnings Show Slight Dip in Revenue — Nov 13, 2024 Risk: medium
  Integrated Biopharma Inc. reported its Q1 2025 results for the period ending September 30, 2024. The company had revenues of $1.091 million and net income of $8
• Integrated Biopharma Inc. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: high
  INTEGRATED BIOPHARMA INC (INBP) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Total revenue for the nine months ended March 31, 2024, was $1,485
• Integrated Biopharma Inc. Files 10-Q for Period Ending December 31, 2023 — Feb 12, 2024 Risk: medium
  INTEGRATED BIOPHARMA INC (INBP) filed a Quarterly Report (10-Q) with the SEC on February 12, 2024. Revenue for the six months ended December 31, 2023, was $1,67

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX